Covariate | Person 1 |
---|---|
Sex | Male |
Age | 63 |
Race | Hispanic |
SBP (mmHg) | 134.7 |
Statin use | No |
Anticoagulant use | No |
BP medication use | Yes |
Currently smoking | No |
Oral diabetes medication use | Yes |
Total cholesterol (mg/dL) | 181 (4.8 mmol/L) |
HDL cholesterol (mg/dL) | 61 (1.4 mmol/L) |
Hemoglobin A1c (%) | 6.1 (51.5 mmol/mol) |
Serum creatinine (mg/DL) | 0.63 (53.0 μmol/L) |
Urine albumin creatinine ratio (mg/g) | 301.6 |
CVD history | No |
CVD risk (10-yr risk, %) | |
Myocardial infarction | 4 |
Stroke | 1 |
Microvascular risk (10-yr risk, %) | |
Nephropathy | 5 |
Retinopathy | 6 |
Neuropathy | 6 |
Drug ranking score (95% CI) based on network meta-analysis | |
1st | SGLT-2-i 1.0 [0.81,1.37] |
2nd | GLP-1RA 0.94 [0.593, 1.39] |
3rd | TZD 0.87 [0.65,1.27] |
4th | SU 0.86 [0.62, 1.31] |
5th | DPP-4 0.77 [0.55, 1.23] |
6th | Basal insulin 0.76 [0.27, 1.39] |